Investigational new drugThyroid Analog
Compound 61450
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061450
Risk Class
LOW
Last Audit
Feb 15, 2108
Research Abstract
Thyroid Analog candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61450 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in investigational new drug with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061450 with updates logged 2108-02-15.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61450Thyroid Analog Program 61450
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061450
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61450